Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. K. Sandhu
Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Prognosis of Fracture: Evaluation of Predictive Accuracy of the FRAX Algorithm and Garvan Nomogram: Rejoinder to Comments by Pluskiewicz and Drozdzowska
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Phase II Trial of Cisplatin Plus Prednisone in Docetaxel-Refractory Castration-Resistant Prostate Cancer Patients
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Phase II, Multicenter, Randomized Trial of Docetaxel Plus Prednisone With or Without Cediranib in Men With Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer
Oncologist
Cancer Research
Medicine
Oncology
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) With Docetaxel in Metastatic Castration‐Resistant Prostate Cancer (mCRPC)
Oncologist
Cancer Research
Medicine
Oncology
Phase I Trial With a Combination of Docetaxel and 153Sm-Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
Pcn336 - Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated With Docetaxel in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase III Trials With Docetaxel-Based Combinations for Metastatic Castration-Resistant Prostate Cancer: Time to Learn From Past Experiences
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel
Japanese Journal of Urology
Urology
Outcome of Combination Chemotherapy With Docetaxel, Estramustine Phosphate, and Carboplatin After Docetaxel and Prednisolone Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Journal of Cancer Therapy
Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review
European Oncology and Haematology
Oncology
Hematology
